On January 13, 2025, the California AG’s Office (“AGO”) issued two legal advisories regarding the application of existing California law to AI generally as well as the use of AI specifically in healthcare.

This blog post introduces the universe of European and national authorities and other relevant actors in the area of supervision and enforcement of the European Union’s Artificial Intelligence Act and provides a brief overview of possible penalties under the AI Act.

This blog post discusses harmonized standards, common specifications, and certificates in the EU’s Artificial Intelligence Act. We also discuss the role of the authorities responsible for appointing conformity assessment bodies and how the latter must perform their activities.

This blog post discusses the EU Artificial Intelligence Act’s measures in support of innovation. These measures will be particularly relevant for companies engaged in research and development activities.

On September 25, 2024, the Federal Trade Commission (FTC) announced the launch of “Operation AI Comply,” an initiative created to tackle unfair and deceptive business practices involving the use of artificial intelligence (AI), particularly false or exaggerated claims about an AI product’s offerings. As part of the initiative’s debut, the FTC announced its crackdown on…

On September 18, the Texas Attorney General (AG) announced a settlement agreement with Pieces Technologies, Inc. (“Pieces”), a Dallas-based healthcare artificial intelligence (AI) research and development firm, resolving allegations that the company made false, misleading or deceptive claims about the accuracy of its healthcare AI products.

This blog post focuses on how the EU’s Artificial Intelligence Act (“AI Act”) regulates generative AI, which the AI Act refers to as General-Purpose AI (“GPAI”) Models.